or
forgot password

    • cancer clinical trials in birmingham, AL

    • Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Large Cell Lymphoma
    Non-small Cell Lung Cancer Registry
    Birmingham Hematology and Oncology Associates
    Birmingham, Alabama 35235
    Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant
    Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy
    University of Alabama at Birmingham-Comprehensive Cancer Ctr.
    Birmingham, Alabama 35294-3300
    Melanoma, Metastases
    Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis
    Center for Education and research on Therapeutics (CERTs) of Musculoskeletal Disorders
    Birmingham, Alabama 35294-3708
    Osteoporosis
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Brain and Central Nervous System Tumors
    Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
    Local Institution
    Birmingham, Alabama
    Chronic Myeloid Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-positive
    Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia
    Local Institution
    Birmingham, Alabama
    Chronic Myelogenous Leukemia
    Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Colorectal Neoplasms
    Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Colorectal Cancer, Metastases
    The Plenaxis® Experience Study
    Millenium Therapeutics & Research - Urology Practice
    Birmingham, Alabama 35205
    Prostate Cancer
    A Safety Study of SGN-40 in Patients With Non-Hodgkin's Lymphoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Non-Hodgkin Lymphoma
    Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia
    Local Institution
    Birmingham, Alabama
    Chronic Myeloid Leukemia, Philadelphia-Positive Myeloid Leukemia
    Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
    University of Alabama
    Birmingham, Alabama
    Vasculitis, Wegener's Granulomatosis, Microscopic Polyangiitis
    Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
    GSK Investigational Site
    Birmingham, Alabama 35209
    Nausea and Vomiting, Chemotherapy-Induced, Chemotherapy-Induced Nausea and Vomiting
    Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Lymphoma
    Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Adenocarcinoma, Neoplasms
    Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
    Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham
    Birmingham, Alabama 35294
    Brain and Central Nervous System Tumors
    A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma

    Birmingham, Alabama 35294
    Carcinoma, Hepatocellular
    Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Lung Cancer
    Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
    Univ of Alabama Birmingham
    Birmingham, Alabama 35294
    Myelodysplastic Syndrome, Iron Overload
    Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients
    University of Alabama Pediatric Hematology/Oncology

    Trial Locations
    University of Alabama Pediatric Hematology/Oncology
    University of Alabama Medical center
    Sickle Cell Disease, Iron Overload, Hemolytic Anemia
    Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Sarcoma
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Head and Neck Cancer
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Breast Cancer
    Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18
    GSK Investigational Site
    Birmingham, Alabama 35209
    Human Papillomavirus (HPV) Infection, Cervical Neoplasia
    Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Mycosis Fungoides, Sezary Syndrome
    Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
    Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham
    Birmingham, Alabama 35294
    Brain and Central Nervous System Tumors
    Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Cervical Cancer
    Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Ovarian Neoplasms
    Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Brain and Central Nervous System Tumors, Unspecified Childhood Solid Tumor, Protocol Specific
    Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Colorectal Neoplasms
    Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL)
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Osteoporosis
    MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Melanoma, Colonic Neoplasms, Breast Neoplasms
    G207 Followed by Radiation Therapy in Malignant Glioma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Malignant Glioma
    Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Breast Cancer
    Abatacept With Methotrexate- Phase IIB
    Local Institution
    Birmingham, Alabama
    Rheumatoid Arthritis
    Community Based Trial for AMEVIVE®
    Monheit Dermatology Associates
    Birmingham, Alabama 35203
    Moderate to Severe Chronic Plaque Psoriasis
    A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer
    Birmingham Cancer Center
    Birmingham, Alabama 35294
    Non-Small Cell Lung Cancer
    Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Neoplasms
    A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients
    Duramed Investigational Site
    Birmingham, Alabama 35234
    Prostate Cancer
    A Study to Compare Human Thrombin Against Bovine Thrombin in Its Ability to Stop Bleeding After Surgery
    Alabama Clinical Therapeutics
    Birmingham, Alabama 35235
    Cardiovascular, Neurologic (Spine), and General Surgery
    A Study of a Monoclonal Antibody, KW-2871, in Patients With Advanced Melanoma
    Comprehensive Cancer Center- University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Stage IV Melanoma
    Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Osteoporosis
    Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)

    Birmingham, Alabama 35294
    Leukemia, Lymphocytic, Chronic, B-Cell
    A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Squamous Cell Carcinoma of the Head and Neck
    FREE Study - Fracture Reduction Evaluation
    University of Alabama
    Birmingham, Alabama
    Osteopenia, Osteoporosis, Multiple Myeloma, Bone Neoplasms
    Conservative Treatment of Postprostatectomy Incontinence
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Urinary Incontinence
    International Immune Tolerance Study
    University of Alabama Birmingham Medical Center
    Birmingham, Alabama 35233
    Hemophilia A With Inhibitors
    Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Metastatic Breast Cancer
    Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive SCLC
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Non-Small Cell Lung Cancer
    Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Breast Neoplasms
    Study of Recombinant Human Thrombin for Bleeding During Surgery
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Cardio Thoracic Surgeons, P.C., Medical Center East / Baptist Montclair
    Cardio Thoracic Surgeons, P.C.
    Surgical Hemostasis
    Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Brain and Central Nervous System Tumors, Thromboembolism
    Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Carcinoma, Non-Small-Cell Lung
    Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Breast Cancer
    A Long-term Safety Study of Infliximab (Remicade)

    Birmingham, Alabama 35294
    Arthritis, Rheumatoid, Crohn Disease, Psoriasis